REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Instytut Biofarmacji Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Instytut Biofarmacji Sp. z o.o. Profile Updated: September 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Instytut Biofarmacji Sp. z o.o. is a company based in Poland, with its head office in Wroclaw. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on January 28, 2019. In 2022, the company reported a net sales revenue drop of 33.33%. Its’ total assets recorded a negative growth of 21.39%. In 2022, Instytut Biofarmacji Sp. z o.o.’s net profit margin increased by 10014.05%.

Headquarters
Ul. Muchoborska 6
Wroclaw; Dolnoslaskie; Postal Code: 54-424

Contact Details: Purchase the Instytut Biofarmacji Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Instytut Biofarmacji Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Instytut Biofarmacji Sp. z o.o. report to view the information.
Incorporation Date:
January 28, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99%
Company Performance
Financial values in the chart are available after Instytut Biofarmacji Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-33.33%▼
Total operating revenue
-33.4%▼
Operating profit (EBIT)
72.88%▲
EBITDA
83.72%▲
Net Profit (Loss) for the Period
66.91%▲
Total assets
-21.39%▼
Total equity
N/A
Operating Profit Margin (ROS)
11518.33%▲
Net Profit Margin
10014.05%▲
Return on Equity (ROE)
N/A
Quick Ratio
-5.26%▼
Cash Ratio
-5.49%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo